INTRODUCTION
============

Major regulation of gene expression mainly depends upon the control of transcription initiation. In particular, the activity of RNA polymerase is regulated to control the level of gene expression. In bacteria, RNA polymerase holoenzyme is composed of core RNAP and a σ factor, which is responsible for the specific recognition and melting of promoter sequence ([@B1]). The σ factors in bacteria can be divided into two classes: the σ^70^ and σ^54^ class ([@B2]). Although they bind to the same core RNAP, these two classes of σ factors have no similarity in primary sequence and the modes of their transcription regulation are very different.

Unlike σ^70^-holoenzyme, the initiation rates of σ^54^-holoenzyme are mainly controlled via regulation of the DNA melting step ([@B3],[@B4]). The σ^54^ -holoenzyme first binds promoter DNA in a transcriptionally silent closed complex ([@B5; @B6; @B7]). Conversion of the closed complex to a transcriptionally proficient open complex requires a specialized activator protein which interacts with σ^54^-holoenzyme through DNA looping and brings about a conformational change in the closed promoter complex in a nucleotide hydrolysis dependent way, leading to σ^54^-holoenzyme isomerization and promoter melting ([@B7; @B8; @B9; @B10; @B11]).

σ^54^ plays an important role in the process of open complex formation and interacts extensively with activator protein, promoter DNA and core RNAP to regulate the proper formation of the open complex. Open complex formation by σ^54^-holoenzyme appears to involve the activator dependent relocation of three structurally distinct σ^54^ domains within the holoenzyme to (i) allow positioning of promoter DNA for entry into the active site of RNAP and (ii) removal of a σ^54^ associated protein density that would otherwise prevent DNA delivery ([@B12]). Based on biochemical and genetic characterization and fragmentation analyses, σ^54^ can be divided into three regions ([@B2],[@B13; @B14; @B15; @B16]) ([Figure 1](#F1){ref-type="fig"}). Region I comprises the amino terminal 56 residues and is important for activator responsiveness ([@B10],[@B17],[@B18]). Region II comprises residues 57--106 and is characterized by a predominance of acidic residues. Region II is not essential for the function of σ^54^. In the carboxyl terminal (residues 107--477) lies Region III which contains a primary core RNAP-binding domain located between residues 120 and 215 ([@B16]), and a DNA-binding domain located between residues 329 and 477 ([@B13],[@B19],[@B20]). A modulation domain lies between these two domains and influences DNA-binding activity indirectly ([@B14]). Figure 1.Diagram of the functional regions of σ^54^ and summary of the results. Grey bar below the diagram of σ^54^ indicates the predicted helical region in Region I. Black bars below the diagram of σ^54^ indicate the helices in the carboxyl terminal DNA binding domain based on the partial structure of σ^54^ from *Aquifex aeolicus* ([@B20],[@B21]). Darker color is used to represent higher activity. The function each color represents is indicated in the left of the figure. The squares at the left of the colored bars indicate the color corresponding to the activity of Cys(--)σ^54^. In the bar representing the activity of σ^54^-activator interaction, the dark blue color indicates the variants that form additional complexes in the presence of PspF~1−275~ and ADP·AlFx. The data are from [Table 1](#T1){ref-type="table"}.

Due to the lack of a high-resolution structure of σ^54^, it is still not clear which residues in σ^54^ are responsible for the interactions with itself or other elements such as core RNAP and promoter DNA in the process of transcription initiation. Nor are the primary σ^54^ sequences of densities evident in electron microscopy studies precisely delineated ([@B12]). To systematically define the functions of each residue in σ^54^, a site-directed mutant library of σ^54^ was constructed using alanine--cysteine scanning mutagenesis. Mutation of residues other than glycine to alanine can be viewed as side-chain deletion and alanine scanning has been widely used in the research of protein functions ([@B21],[@B22]), while mutation to cysteine can facilitate site specific protein modification ([@B23; @B24; @B25]). Alanine--cysteine scanning mutagenesis used in this article combines the advantages of these two kinds of mutations and facilitates both structural and functional analyses of a protein.

Here, residues 3--476 of a cysteine free form of *Klebsiella pneumoniae* σ^54^ were changed to alanine and cysteine in groups of two consecutive residues, producing a total of 237 variants of σ^54^. This single cysteine mutant library is very helpful in both the structural and functional analyses of σ^54^, and this paper focuses on the latter.

The results indicate that: (i) two parts of the Region I are the main targets for activator interaction; (ii) the carboxyl terminal of modulation domain can affect σ^54^ isomerization, probably through it influencing the −12 promoter sequence interaction; (iii) the carboxyl terminal part of DNA-binding domain is important for maintain the *in vivo* integrity of σ^54^, but less important in the regulation of σ^54^ activity. The linkage between different functions of σ^54^ and possible mechanisms are discussed. The single cysteine mutant library of σ^54^ provides a powerful tool for further structural analyses using ensemble and single molecule Foster Resonant Energy Transfer (FRET) approaches ([@B26]).

MATERIALS AND METHODS
=====================

Site-directed mutagenesis
-------------------------

The pET28 based plasmid pSRWCys(−) ([@B25]), which directs the synthesis of the amino-terminal 6-His-tagged Cys(−)σ^54^, was used as the template to create the single cysteine variants of σ^54^ using the Quickchange mutagenesis kit (Stratagene). The whole *rpoN* gene directing the synthesis of σ^54^ protein in each mutated plasmid was sequenced to ensure that only the desired substitutions were present.

β-Galactosidase assays
----------------------

Plasmids carrying mutated *rpoN* genes were transformed to *Escherichia coli rpoN* knockout strain TH1/pMB221 ([@B27]). pMB221 contains both the reporter gene *lacZ* and the activator gene *nifA*. The reporter gene *lacZ* is under the control of *K. pneumoniae nifH* promoter, and the activator NifA is expressed from *bla* promoter. Transformants were grown at 37°C and then 100 μl of the overnight culture was used to inoculate 10 ml of LB with 50 μg/ml kanamycin and 34 μg/ml chloromycetin. Cells were grown at 37°C until A~600~ reaches 0.8. σ^54^-dependent gene expression in this system depend on a basal T7-RNAP independent expression of *rpoN* from pET28. The average β-galactosidase results from three independent colonies are presented.

Immunoblotting
--------------

Mutated plasmids were transformed to TH1/pMB221 and were cultured under the same condition used in β-galactosidase assays. Cells (1 ml) were then collected by centrifugation and resuspended in 60 μl of 10 mM Tris, 0.1 mM EDTA, pH 7.9. Ten microliters of the concentrated cell solution was lysed with 10 μl of 2× SDS sample buffer, heated at 95°C and 10 μl of each were loaded. Proteins were separated on denaturing 8% SDS--PAGE gels and blotted onto PVDF membranes. Anti-σ^54^ (prepared by Institute of Genetics and Developmental Biology, Chinese Academy of Sciences) and alkaline phosphatase conjugated anti-rabbit IgG (Pierce) were used for detection.

Protein purification
--------------------

Mutated σ^54^ proteins were overexpressed in *E. coli* B834 (DE3). Two hundred microliters of overnight cultures were used to inoculate 20 ml of LB with 50 μg/ml kanamycin and cells were grown at 37°C until A~600~ reached 0.6. The cultures were then shifted to 25°C and IPTG was added to 1 mM. Incubation continued for 2 h at 25°C. Cells were collected by centrifugation, and resuspended in 500 μl of Buffer A \[25 mM sodium phosphate (pH 7.0), 50 mM NaCl, 5% (v/v) glycerol\]. The concentrated cells were lysed by adding 55 μl of FastBreak™ Reagent (Promega) into the buffer and were shaken for 15 min at room temperature. The lysates were then incubated for 3 min with 450 μl of Ni--NTA resin (Qiagen) in the columns, which were then washed with 500 μl of Buffer B (25 mM sodium phosphate (pH 7.0), 50 mM NaCl, 30 mM imidazole, 5% (v/v) glycerol). Mutated σ^54^ proteins were eluted in 400 μl of Buffer C \[25 mM sodium phosphate (pH 7.0), 50 mM NaCl, 1 M imidazole, 5% (v/v) glycerol\]. Purified σ^54^ proteins were dialysed against 10 mM Tris (pH 7.5), 0.1 mM EDTA, 100 mM NaCl, 50% glycerol, and stored at −20°C.

Core RNAP-binding assays
------------------------

*E. coli* core RNAP (Epicentre, 250 nM) and different amounts of σ^54^ variants were mixed together in Tris--NaCl buffer (40 mM Tris--HCl (pH 8.0), 10% (v/v) glycerol, 0.1 mM EDTA, 1 mM DTT, 100 mM NaCl) and incubated for 10 min at 30°C, followed by the addition of glycerol bromophenol blue loading dye. Samples were loaded onto native 4.5% PAGE gels and run at 50 V for 2 h at room temperature in TG buffer (25 mM Tris, 200 mM glycine, pH 8.6). Proteins were visualized by Coomasie Blue staining.

Gel mobility shift assay
------------------------

^32^P-labeled 88-mer top strand −12/−11 mismatched heteroduplex DNA fragment consisting of the −60 to +28 *Sinorhizobium meliloti nifH* promoter sequence was used as a template for gel mobility shift assays. The reactions contained 20 nM DNA, 1 μM σ^54^ in STA buffer \[25 mM Tris--acetate (pH 8.0), 8 mM magnesium acetate, 10 mM KCl, 3.5% (w/v) PEG 8000\] and were incubated for 10 min at 30°C. Where indicated, PspF~1−275~ (5 μM), dGTP (4 mM) were added for 5 min prior to gel loading. Free DNA and σ^54^ bound DNA were separated on 4.5% native PAGE gels and run at 80 V for 70 min at room temperature in TG buffer (25 mM Tris, 200 mM glycine, pH 8.6). Quantitative data were from phosphorimager analyses of the gels.

σ^54^-activator interaction
---------------------------

Twenty micromolar PspF~1−275~ and 1 μM of σ^54^ were incubated at 30°C for 5 min in the above STA buffer with ADP (0.2 mM) and NaF (5.0 mM). After addition of AlCl~3~ (0.2 mM) the samples were incubated for a further 10 min and loaded onto 4.5% native PAGE gels and run at 120 V for 50 min at room temperature in the above TG buffer. Proteins were visualized by Coomassie Blue staining.

Abortive transcription assay
----------------------------

Open complexes were formed on plasmid pMKC28 ([@B28]) (10 nM final concentration) in the presence of 100 nM σ^54^-holoenzyme (constituted using 2.5:1 molar ratio of σ^54^ over core RNAP), 20 U RNase inhibitor, 4 mM dATP and 5 μM of PspF~1−275~. A mix containing 100 μg/ml heparin, 0.5 mM UpG, 4 μCi \[α-^32^P\] GTP was added to the reaction for the abortive synthesis of a four nucleotide transcript (UGGG). The reactions were separated on a 20% denaturing gel and quantified as in gel mobility shift assay. Replicate assays were conducted to confirm the low activities of the variants defective in abortive transcription.

RESULTS
=======

Mutagenesis
-----------

σ^54^ from *K. pneumoniae* contains two cysteine residues at positions 198 and 346 ([@B29]). Substitution of these two cysteine residues with alanine does not affect the function of σ^54^ significantly ([@B25]). Therefore, in order to construct variants carrying a single cysteine, the pET28b based plasmid pSRWCys(--), which directs the synthesis of the Cys(--)σ^54^, was used as the template ([@B25]). Residues of Cys(--)σ^54^ from 3 to 476 were systematically substituted with alanine--cysteine in groups of two adjacent residues at a time, for a total of 237 variants of σ^54^. Substitution with alanine can be viewed as a side-chain deletion, whereas substitution with cysteine facilitates side-chain modification at specific positions. Each mutated *rpoN* gene was sequenced in its entirety to establish the presence of only the expected substitutions.

Region II is not essential for the *in vivo* activity of σ^54^
--------------------------------------------------------------

β-Galactosidase assays were used to test the *in vivo* activities of the variants. The plasmid carrying the mutated *rpoN* gene and another plasmid, pMB221 carrying the reporter and activator genes ([@B27]), were transformed to *E. coli* TH1, which lacks functional σ^54^. The expression of mutated σ^54^ depends on the low level of basal expression of *rpoN* gene from the pET28 based vector. The β-galactosidase gene is under the control of *K. pneumoniae nifH* promoter and the activator NifA is constitutively expressed from the *bla* promoter. NifA acts with σ^54^ to activate the expression of β-galactosidase gene from σ^54^ dependent *nifH* promoter. Therefore, the activity of β-galactosidase can be used to indicate the *in vivo* activity of σ^54^ variants.

The mutations that affected the *in vivo* activity of σ^54^ are distributed extensively in Region I and III, and are relatively concentrated in the carboxyl terminal of σ^54^ that includes the −24 DNA-binding bihelical structure ([@B30]) ([Table 1](#T1){ref-type="table"}). Consistent with the fact that Region II is not well conserved in sequence, none of the Region II variants exhibited poor activity. Table 1.Summary of the activities of σ^54^ variants[^a^](#TF1){ref-type="table-fn"}σ^54^ mutantFunctional region*In vivo* trxn[^b^](#TF2){ref-type="table-fn"}Core bindingActivator contactEarly melted DNA bindingIsomerizationAbortive trxnCys(--)100wt-like+100100100Region I    AC3/4Activation31wt-like+863439    AC5/6Activation59weak+938383    AC7/8Activation51wt-like+852248    AC9/10Activation66wt-like+884149    AC11/12Activation35wt-like+/−91018    AC13/14Activation76wt-like+107098    AC15/16Activation18wt-like+89044    AC17/18Activation23wt-like−66016    AC19/20Activation9weak+465942    AC21/22Activation27wt-like+297840    AC23/24Activation1wt-like+635219    AC25/26Activation6wt-like+21025    AC27/28Activation47wt-like+77037    AC29/30Activation16wt-like−19014    AC31/32Activation72wt-like+95042    AC33/34Activation16wt-like+7015    AC35/36Activation75wt-like+90034    AC37/38Activation8wt-like−1514421    AC39/40Activation75wt-like+925229    AC41/42Activation109wt-like+72047    AC43/44Activation49wt-like+585531    AC45/46Activation30wt-like+952671    AC47/48Activation4wt-like−14023    AC49/50Activation84wt-like+92168109    AC51/52Activation72wt-like+10211059    AC53/54Activation81wt-like+9810987    AC55/56Activation71wt-like+9210557Region II    AC57/58Acidic72wt-like+957246    AC59/60Acidic81wt-like+97101128    AC61/62Acidic71wt-like+789878    AC63/64Acidic83wt-like+948980    AC65/66Acidic117wt-like+909345    AC67/68Acidic108wt-like+899476    AC69/70Acidic81wt-like+939687    AC71/72Acidic92wt-like+888438    AC73/74Acidic44wt-like+889875    AC75/76Acidic128wt-like+909946    AC77/78Acidic133wt-like+869751    AC79/80Acidic37wt-like+889174    AC81/82Acidic102wt-like+8910476    AC83/84Acidic70wt-like+[^c^](#TF3){ref-type="table-fn"}9919251    AC85/86Acidic97wt-like+92119100    AC87/88Acidic47wt-like+9295145    AC89/90Acidic76wt-like+8716492    AC91/92Acidic38wt-like+8790117    AC93/94Acidic39wt-like+74117117    AC95/96Acidic78wt-like+8189120    AC97/98Acidic28wt-like+86102148    AC99/100Acidic122wt-like+79108111    AC101/102Acidic104wt-like+8797117    AC103/104Acidic108wt-like+889389    AC105/106Acidic109wt-like+959872Region III    AC107/108Core binding110wt-like+9411029    AC109/110Core binding66wt-like+1006034    AC111/112Core binding111wt-like+927823    AC113/114Core binding72wt-like+908125    AC115/116Core binding97wt-like+818557    AC117/118Core binding79wt-like+796685    AC119/120Core binding33wt-like+10118946    AC121/122Core binding88weak−5318138    AC123/124Core binding8wt-like+/−9322551    AC125/126Core binding14wt-like+/−10713120    AC127/128Core binding8wt-like+/−968937    AC129/130Core binding60wt-like+9366148    AC131/132Core binding63wt-like+958333    AC133/134Core binding16wt-like−6513846    AC135/136Core binding65wt-like+9269127    AC137/138Core binding19wt-like−879536    AC139/140Core binding61weak−88113152    AC141/142Core binding100wt-like+8875174    AC143/144Core binding107wt-like+97102114    AC145/146Core binding16wt-like+/−927824    AC147/148Core binding89wt-like+10267124    AC149/150Core binding96wt-like−752777    AC151/152Core binding6weak−818364    AC153/154Core binding24wt-like+107037    AC155/156Core binding83wt-like+9855185    AC157/158Core binding102wt-like+10075153    AC159/160Core binding32wt-like−4485115    AC161/162Core binding27wt-like−9011386    AC163/164Core binding100wt-like+8577117    AC165/166Core binding83wt-like−1029587    AC167/168Core binding87wt-like+7285104    AC169/170Core binding79wt-like+9798142    AC171/172Core binding106wt-like+10397172    AC173/174Core binding65wt-like−828767    AC175/176Core binding65weak−91106126    AC177/178Core binding74wt-like−80168103    AC179/180Core binding23weak−8021829    AC181/182Core binding52wt-like−78169136    AC183/184Core binding47wt-like+8112326    AC185/186Core binding2wt-like−8314343    AC187/188Core binding9wt-like−9011527    AC189/190Core binding115wt-like−6971154    AC191/192Core binding92wt-like+8790156    AC193/194Core binding21wt-like+90147190    AC195/196Core binding30wt-like+/−81153113    AC197/198Core binding99wt-like+88181104    AC199/200Core binding12wt-like−5720126    AC201/202Core binding27wt-like−6413127    AC203/204Core binding55wt-like−6416964    AC205/206Core binding98wt-like−95134138    AC207/208Core binding85wt-like+2818877    AC209/210Core binding69wt-like−2114856    AC211/212Core binding87wt-like+9310769    AC213/214Core binding96wt-like−8612247    AC215/216Core binding71wt-like−4413638    AC217/218Modulation97wt-like+6918061    AC219/220Modulation23wt-like−3826926    AC221/222Modulation89wt-like+7712674    AC223/224Modulation25wt-like−4313816    AC225/226Modulation108wt-like+7914435    AC227/228Modulation5wt-like+9114046    AC229/230Modulation59wt-like+7214461    AC231/232Modulation61weak−5712242    AC233/234Modulation62wt-like+3323056    AC235/236Modulation30wt-like−4617533    AC237/238Modulation69wt-like+4713140    AC239/240Modulation90wt-like+/−566343    AC241/242Modulation74weak−2014332    AC243/244Modulation77wt-like−7810957    AC245/246Modulation70wt-like+7517156    AC247/248Modulation72wt-like−668549    AC249/250Modulation89wt-like+9211576    AC251/252Modulation52wt-like+/−4712456    AC253/254Modulation23weak−8713962    AC255/256Modulation74wt-like−5313560    AC257/258Modulation89wt-like+7114575    AC259/260Modulation24wt-like+8418720    AC261/262Modulation86wt-like+8014544    AC263/264Modulation102wt-like+8512560    AC265/266Modulation107wt-like+9811476    AC267/268Modulation98wt-like+9814682    AC269/270Modulation47wt-like+9611850    AC271/272Modulation86wt-like+979274    AC273/274Modulation71wt-like+8210250    AC275/276Modulation102weak−6915318    AC277/278Modulation78weak−5912831    AC279/280Modulation91weak+/−5115333    AC281/282Modulation106wt-like+6713651    AC283/284Modulation102wt-like+/−7310343    AC285/286Modulation7weak−889527    AC287/288Modulation61wt-like+10610063    AC289/290Modulation49wt-like+/−816843    AC291/292Modulation78wt-like+798935    AC293/294Modulation92wt-like+8810350    AC295/296Modulation103wt-like+17036    AC297/298Modulation28weak+/−815330    AC299/300Modulation8wt-like+[^c^](#TF3){ref-type="table-fn"}18027    AC301/302Modulation96wt-like+[^c^](#TF3){ref-type="table-fn"}5014238    AC303/304Modulation20wt-like+[^c^](#TF3){ref-type="table-fn"}629632    AC305/306Modulation55wt-like+[^c^](#TF3){ref-type="table-fn"}5113360    AC307/30892wt-like+[^c^](#TF3){ref-type="table-fn"}5818551    AC309/310119wt-like+[^c^](#TF3){ref-type="table-fn"}3716342    AC311/31268wt-like+[^c^](#TF3){ref-type="table-fn"}3917331    AC313/314103wt-like+/−5012251    AC315/31695wt-like+/−6123734    AC317/31817weak+[^c^](#TF3){ref-type="table-fn"}6714142    AC319/3206wt-like+645420    AC321/322124wt-like+9018136    AC323/32452wt-like+83022    AC325/32648wt-like+489221    AC327/32812wt-like+395915    AC329/330Xlink7wt-like+445116    AC331/332Xlink39wt-like+817232    AC333/334Xlink5wt-like+/−1329421    AC335/336Xlink9weak+7045    AC337/338Xlink89wt-like+/−807126    AC339/340Xlink34wt-like+/−1326530    AC341/342Xlink73weak−4615236    AC343/344Xlink93weak−857322    AC345/346Xlink86wt-like+9310740    AC347/34812[^d^](#TF4){ref-type="table-fn"}weak−1029013    AC349/35099wt-like+10115858    AC351/35233weak+117741    AC353/35441weak−6114439    AC355/3564wt-like−319315    AC357/35816weak+/−[^c^](#TF3){ref-type="table-fn"}2050427    AC359/36093weak--5814852    AC361/36237weak+/−[^c^](#TF3){ref-type="table-fn"}5017554    AC363/36449wt-like+/−[^c^](#TF3){ref-type="table-fn"}730642    AC365/366HTH95weak−4123549    AC367/368HTH75weak−1734343    AC369/370HTH29weak−1224616    AC371/372HTH69wt-like+9510929    AC373/374HTH79wt-like+979443    AC375/376HTH91weak+927820    AC377/378HTH68weak+/−8812433    AC379/380HTH2wt-like+10165419    AC381/382HTH45weak−1060032    AC383/384HTH0wt-like+163716    AC385/386HTH10wt-like+786666    AC387/38823wt-like+562730    AC389/39016weak−6711131    AC391/39298wt-like+10412039    AC393/39450weak−7114628    AC395/39642weak−5014660    AC397/39885weak−8411881    AC399/40023weak−1414230    AC401/40225weak+/−3012269    AC403/4047weak+/−3013125    AC405/40645wt-like+9512341    AC407/40820wt-like+/−7417931    AC409/41061wt-like+[^c^](#TF3){ref-type="table-fn"}7115355    AC411/41239wt-like+[^c^](#TF3){ref-type="table-fn"}5920570    AC413/41487wt-like+[^c^](#TF3){ref-type="table-fn"}9412352    AC415/41653wt-like+[^c^](#TF3){ref-type="table-fn"}992954    AC417/41827wt-like+8113334    AC419/42072wt-like+9011367    AC421/422122wt-like+9812844    AC423/42410wt-like−28369115    AC425/42612weak+[^c^](#TF3){ref-type="table-fn"}1857468    AC427/42816wt-like+/−39296107    AC429/43090wt-like+/−9111985    AC431/4320[^d^](#TF4){ref-type="table-fn"}wt-like+/−320241    AC433/43446wt-like+/−5917779    AC435/43618wt-like−6219096    AC437/4388[^d^](#TF4){ref-type="table-fn"}wt-like+7812477    AC439/4400[^d^](#TF4){ref-type="table-fn"}wt-like+/−1033934    AC441/44215wt-like+17356135    AC443/44496wt-like+[^c^](#TF3){ref-type="table-fn"}8913882    AC445/44613wt-like+8410399    AC447/44896wt-like+[^c^](#TF3){ref-type="table-fn"}8911692    AC449/4508[^d^](#TF4){ref-type="table-fn"}wt-like+6917159    AC451/45221wt-like+[^c^](#TF3){ref-type="table-fn"}58150112    AC453/454RpoN box34wt-like+[^c^](#TF3){ref-type="table-fn"}6021067    AC455/456RpoN box0wt-like+67023    AC457/458RpoN box0[^d^](#TF4){ref-type="table-fn"}wt-like+225165    AC459/460RpoN box23wt-like+[^c^](#TF3){ref-type="table-fn"}35210121    AC461/462RpoN box0[^d^](#TF4){ref-type="table-fn"}wt-like+4215628    AC463/464RpoN box86wt-like+[^c^](#TF3){ref-type="table-fn"}10414171    AC465/46652wt-like+[^c^](#TF3){ref-type="table-fn"}7410999    AC467/4681[^d^](#TF4){ref-type="table-fn"}wt-like+2430362    AC469/47099wt-like+9314661    AC471/47266wt-like+[^c^](#TF3){ref-type="table-fn"}1013258    AC473/4740[^d^](#TF4){ref-type="table-fn"}wt-like+1917423    AC475/47632wt-like+[^c^](#TF3){ref-type="table-fn"}3213470[^1][^2][^3][^4][^5]

Low activities of the variants could be caused by protein instability. Immunoblotting was therefore carried out to measure the expression levels of the variants which retained \<20% activity compared to Cys(--)σ^54^. σ^54^ variants were expressed under the same condition used in the *in vivo* activity assay. Variants found at lower than wild-type expression levels have substitutions mainly located in the DNA-binding domain \[AAs 329--477, defined previously by proteolysis experiments and including the −24 promoter recognition structure ([@B30],[@B31])\], especially in the carboxyl terminal, between residues 431 and 476 ([Figure 2](#F2){ref-type="fig"}), indicating that many residues in this region are important for maintaining the structural integrity of σ^54^ *in vivo*, and that the instabilities of these variants may be one of the reasons for their low *in vivo* activities. However, the series of purified σ^54^ variants changed in residues 457--476 migrated as discrete bands in native gels, each with a mobility similar to the Cys(--)σ^54^ (when loaded at higher concentrations for detection), suggesting that their gross structural integrity is not seriously affected *in vitro* ([Figure S1A](http://nar.oxfordjournals.org/cgi/content/full/gkp419/DC1)). These variants were detected in native gels at concentrations where the Cys(--)σ^54^ was not easily detected, indicating a less diffuse behavior, and by inference some differences in conformation compared to the control protein Cys(--)σ^54^. Figure 2.*In vivo* stability of σ^54^ variants which retained \<20% *in vivo* activity compared to Cys(-)σ^54^. The functional regions in which these variants are located are also shown. The asterisks indicate the variants with very low expression levels. Immunoblots were of lysates of TH1 cells used in *in vivo* activity assays, containing pMB221 and mutant *rpoN* genes. Equal amounts of each cell extract were loaded. Immunoblots of purified σ^54^ samples are also shown presented at 4, 8 and 12 ng.

Residues contributing to core RNAP binding are extensively distributed throughout Region I and III
--------------------------------------------------------------------------------------------------

Next, all the variants as well as Cys(--)σ^54^ were purified by Ni affinity chromatography for further functional analyses *in vitro*. An essential and first step en route to open complex formation is holoenzyme forming between σ and core RNAP. Native gel mobility shift assay was used to measure the binding of σ^54^ variants to core RNAP. Holoenzyme can be detected in Coomassie blue stained gels based on its different mobility versus core RNAP.

Consistent with the view that the core RNAP interface of σ^54^ comprises at least two functionally important but distinct sequences: 1--56 and 120--215 ([@B16]), many mutations located in these two sequences altered the interaction of σ^54^ with core RNAP: Variants AC 5/6, AC 19/20, AC 121/123, AC 139/140, AC 151/152, AC 175/176 and AC 179/180 shifted all core RNAP at a molar ratio of 4:1 (σ^54^: core RNAP), whereas Cys(--)σ^54^ can shift all core RNAP at a molar ratio of 1:1 ([Figure 3](#F3){ref-type="fig"}). In Region I, mutations that affected binding of σ^54^ to core RNAP mainly locate in its amino terminus, while mutations between residues 39--56 had no effect upon holoenzyme formation ([Figure S1A](http://nar.oxfordjournals.org/cgi/content/full/gkp419/DC1)). Furthermore, in this assay, many residues in modulation domain or DNA-binding domain were found to be important for core RNAP binding ([Figure 3](#F3){ref-type="fig"}), indicating residues affecting interaction of σ^54^ with core RNAP are widely distributed across Regions I and III. Although Region II is reported to play a role in the binding of σ^54^ to core RNAP ([@B32]), none of the mutations in Region II affected the core RNAP-binding activities in our assays ([Figure S1B](http://nar.oxfordjournals.org/cgi/content/full/gkp419/DC1)). Figure 3.Formation of holoenzyme by σ^54^ variants which bind core RNAP with low affinity. Holoenzyme were formed at 1:1, 1:2 and 1:4 ratios of core RNAP (250 nM) to σ. Migration positions of core RNAP, holoenzyme and free σ are indicated.

Regions I and III cooperate for activator interaction
-----------------------------------------------------

σ^54^-Holoenzyme initiates transcription in response to an interaction with an activator protein, and σ^54^ is the major and direct target for this interaction ([@B7],[@B33],[@B34]). To identify the residues in σ^54^ responsible for the stable interaction with activator protein, an assay to measure the interaction between the σ^54^ and the activator protein by native-PAGE of the reaction was used. A DNA-binding domain deletion form of the *E. coli* phage shock protein F (PspF~1−275~) served as a model activator in these assays ([@B35]). Since the interaction between σ^54^ and its activators is normally very transient, stable complex formation between σ^54^ and PspF~1−275~ depends on ADP·AlFx---an ATP analog that mimics the state of ATP at the point of hydrolysis, which 'traps' the transient complex between PspF~1−275~ and σ^54^ so that it can be resolved and detected on native gels ([@B34]).

Results show that four Region I variants (AC17/18, AC29/30, AC37/38 and AC47/48.) failed to form the ADP·AlFx dependent stable complex with PspF~1−275~, indicating the substituted residues contribute to part of the interface σ^54^ makes with activator protein ([Figure 4](#F4){ref-type="fig"}). Mutations of these residues may alter this interface and prevent the variants from making stable interaction with activator protein. Low *in vivo* activities of these four variants may also be attributed to their altered interaction with activator protein. Figure 4.σ^54^ variants which cannot bind PspF~1--275~ normally in the presence of ADP·AlFx. ADP·AlFx dependent complexes formed between σ^54^ and PspF~1--275~ were detected by Coomassie staining. σ^54^ and PspF~1--275~ were presented at 1 and 20 μM separately. Arrow (a) indicates the complex formed between σ^54^ and PspF~1--275~ in the presence of ADP·AlFx. Arrow (b) indicates the changed position of PspF~1--275~ complex in the presence of ADP·AlFx. Arrow (c) and (d) indicates the new bands formed in this assay.

Many Region III variants also cannot form a detectable stable complex with PspF~1−275~, implying that determinants contributing to the interface between σ^54^ and activator protein are widely distributed. Considering that Region I constitute the primary target for activator interaction ([@B34]), it is probable that substitution of these Region III residues indirectly affect the stable σ^54^-activator complex formation through the interaction with Region I.

Interestingly, some σ^54^ variants in the trapping reactions showed formation of a new complex which has not been observed before. This new complex has a slower mobility compared to the normal σ^54^-activator complex ([Figure 4](#F4){ref-type="fig"}). We speculate that this new complex might be a σ^54^-activator complex with a new conformation, caused by the altered interaction of σ^54^ with PspF~1−275~. The new complexes were detected under conditions supporting PspF--ADP·AlFx formation, but we did not determine if all the reaction components (AlCl, NaF, ADP) were required. However, the presence of ADP alone was not sufficient for formation of new complexes (data not shown). Among the variants with this phenotype, most have substitutions located in Region III and only one variant was in Region II, residues 83--84.

Promoter DNA binding
--------------------

σ^54^ is a DNA-binding protein that can *in vitro* occupy some of its cognate promoters in the absence of core RNAP ([@B36]). Interaction of σ^54^ with repressive fork junction promoter sequences around −12 plays an important role in the regulation of open complex formation ([@B12],[@B37; @B38; @B39]). To determine the σ^54^ sequences that contribute to promoter DNA binding, we conducted DNA-binding assay using heteroduplex promoter DNA (opened at −12 and −11, termed early melted DNA) to mimic the state of DNA in the closed complex ([Figure 5](#F5){ref-type="fig"}A). Mutations that affected early melted DNA binding mainly located in two regions: the carboxyl terminal of Region I (residues from 25 to 48) and the DNA-binding domain (residues from 329 to 477). In Region I (residues from 25 to 38), it is interesting to note the periodicity of the DNA-binding defective phenotype ([Figure 5](#F5){ref-type="fig"}B). Some other mutations located in modulation domain (residues 207--210, 241--242 and 295--300) also affect early melted DNA binding, consistent with the view that modulation domain functions to assist DNA binding ([@B14]). Figure 5.(**A**) *S. meliloti nifH* heteroduplex promoter probe used for DNA binding and σ^54^ isomerization assay. The consensus GG and GC elements are underlined. The mismatched region and transcription start sequence are boxed in black. (**B**) The amounts of σ--DNA and ssσ--DNA complex resulting from the action of PspF~1--275~ and dGTP are plotted. Only the examples of variants that fail to bind DNA, form ssσ--DNA complex, or variants that more readily form the ssσ--DNA complex are shown. I. Sigma binding to early melted DNA. II. ssσ--DNA complex formation in the presence of PspF~1--275~ and dGTP.

Variants defective in early melted DNA-binding function abnormally in isomerization assay
-----------------------------------------------------------------------------------------

σ^54^ bound to early melted DNA responds to activator protein in the presence of an hydrolysable NTP source and isomerizes independently of core RNAP to form a new slower migrating 'supershifted (ss)' DNA complex ([@B33]). To characterize the sequences in σ^54^ that contribute to activator responsiveness, we attempted to form the isomerized supershifted σ--DNA complex (ssσ--DNA) using activator PspF~1−275~ and hydrolysable nucleotide dGTP. For each variant, a comparison of the fraction of initially bound DNA converted, in an activator and hydrolysable nucleotide dependent way, to the new isomerized ssσ--DNA species was made. Reactions without hydrolysable nucleotide were also conducted to potentially identify any variant that can response to activator protein in a hydrolysable nucleotide independent way. However, we failed to detect any variant with this phenotype, indicating the importance of hydrolysable nucleotide to the normal function of activator protein (data not shown).

The σ^54^ isomerization assay revealed two classes of variants that behave differently from Cys(--)σ^54^. The first class of variants is represented by some Region I variants which failed to form the isomerized ssσ--DNA species. This phenotype is also shared with some other variants that have substitutions located in core RNAP-binding domain (153--154), carboxyl terminal of modulation domain (295--296, 299--300), and DNA-binding domain (323--324, 335--336 and 455--456) ([Figure 5](#F5){ref-type="fig"}B). However, residues that contribute to σ^54^ isomerization mainly located in two parts of Region I (11--18 and 25--36), indicating that Region I comprises the major elements influencing activator responsiveness, but likely interacts with other parts of σ^54^. The second class of variants is represented by some Region III variants. In striking contrast to the first class, this class of variants can form isomerized ssσ--DNA species much more efficiently than Cys(--)σ^54^ ([Figure 5](#F5){ref-type="fig"}B). As expected, early melted DNA binding seems to be important to the normal formation of ssσ--DNA, since most variants defective in early melted DNA binding either failed to form ssσ--DNA (represented by Region I variants), or formed ssσ--DNA much more efficiently (represented by Region III variants) ([Figure 5](#F5){ref-type="fig"}B and [Table 1](#T1){ref-type="table"}). The latter group of variants seem to have a reduced barrier to being isomerized, implying Region III residues keep isomerization in check and that σ^54^ could function through concerted changes in the organization of its domains.

Transcription activities of the variants in carboxyl terminal of DNA-binding domain are restored *in vitro*
-----------------------------------------------------------------------------------------------------------

To further define the elements in σ^54^ that contribute to open complex formation and transcription initiation, abortive transcription assays were conducted from a supercoiled *S. meliloti nifH* promoter template (pMKC28) ([@B28]), whose sequence from −1 to +3 is TGGG ([Figure 5](#F5){ref-type="fig"}A). If the activator PspF~1−275~ and dATP (needed for the ATPase activity of the activator protein) were provided, the tetranucleotide UGGG can be synthesized by σ^54^-holoenzyme in the presence of the priming dinucleotide UpG, and transcription substrate GTP. Heparin was also added together with GTP and after dATP plus PspF to measure transcription from a single round of activation.

The *in vitro* transcription activities of σ^54^ variants were largely in accordance with their *in vivo* activity, but in the carboxyl terminal of DNA-binding domain, many variants with low *in vivo* activity functioned normally in the abortive transcription assay ([Table 1](#T1){ref-type="table"} and [Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gkp419/DC1)). Considering the low *in vivo* expression levels of these variants detected by immunoblotting, the low *in vivo* activities of these variants could be attributed to their *in vivo* instability or reduced abilities to compete with other σ factors *in vivo*, and these defects are not operational *in vitro*. Notably for many variants that had improved activities in forming the isomerized ssσ--DNA species, the abilities of the holoenzyme they formed to initiate transcription were seldom improved, sometimes even impaired ([Figure 6](#F6){ref-type="fig"} and [Table 1](#T1){ref-type="table"}), demonstrating the influence of steps after σ^54^ isomerization to open complex formation and suggesting coordinated changes in σ^54^ and core RNAP structure are required for making activator dependent open complexes. Figure 6.Mutations in σ^54^ that affect transcription initiation. Autoradiograph of the denaturing gel showing the synthesis of abortive transcripts from holoenzyme formed with σ^54^ variants which affect transcription initiation.

DISCUSSION
==========

Cryo-EM reconstruction of σ^54^--holoenzyme reveals four density regions (D1, Db, D2 and D3) attributable to σ^54^. Region I sequence, including the −12 recognition region, is within Db density which is located at the position of DNA loading into the RNAP active centre, and is suggested to prevent the active centre from accessing the template DNA strand, therefore inhibiting the spontaneously formation of the open complex from double stranded DNA. Interaction of activator protein and σ^54^ likely causes a conformational change of Region I which removes the steric obstruction and modifies the interaction with −12 promoter to allow the loading of the template strand into the active centre, leading to open complex formation ([Figure 7](#F7){ref-type="fig"}) ([@B12]). Our results fully support this model, indicating that Region I is the major element interacting with activator protein and plays an important role in coordinating activator responsiveness. Although several distinct activities reside in discrete parts of σ^54^, residues of σ^54^ contributing to core RNAP binding or activator contacting are widely distributed across Regions I and III of σ^54^, consistent with the observation that multiple interactions with core RNAP occur with several domains of σ^54^ and that the main connecting density between PspF~1−275~ and σ^54^--holoenzyme occurs not only at the interface of Db, but also at D1 and D2 which contain major core RNAP-binding element of σ^54^ and part of Region III of σ^54^ ([@B12]). These residues probably constitute the surfaces of the density regions through which σ^54^ exerts its influence upon the reorganization of RNAP. Figure 7.The left panel shows the cryo-EM reconstruction of σ^54^-holoenzyme bound to the activator protein in the absence of promoter DNA ([@B12]). Shown in green and yellow are the positions of the σ^54^ densities before and after binding to the activator protein, respectively. The σ^54^-holoenzyme is shown alone (light blue) and in complex with the activator PspF~1--275~ (red). The middle and right panels show cartoons depicting the structural changes inferred from cryo-EM reconstruction of the σ^54^-holoenzyme and σ^54^-holoenzyme bound by the activator protein. The promoter DNA is shown as an orange line: In the 'CC conformation' σ^54^ domains D2 and D3 contact the −24 and −12 consensus promoter sequences upstream of the +1 site, respectively, thereby distorting DNA next to −12. The interaction with the activator protein (red/pink) in a mixed nucleotide state is thought to enable σ^54^-holoenzyme to adopt a conformation similar to that in the intermediate complex (stabilized experimentally with ADP·AlFx).

Roles of Region I sequences
---------------------------

The amino terminal Region I plays a central role in activator responsiveness and may act as an organizing centre that brings the key σ^54^, core RNAP and DNA component together ([@B10],[@B40],[@B41]). Mutations affecting σ^54^ function located between residues 15 and 47 have been described previously ([@B18],[@B21]), and we identified one additional sequence affecting activator responsiveness of σ^54^, residues 11--14 ([Figure 1](#F1){ref-type="fig"}). Most mutations affecting σ^54^ isomerization were located between residues 11--18 and 25--36, suggesting these two sequences are the primary sequences for activator responsiveness. Since the −12 promoter sequence was shown to have a role in contributing to supershifted ssσ--DNA complex formation ([@B33]), for some variants defective in early melted DNA binding (AC25/26, 29/30, 33/34, 47/48), the failure to form isomerized ssσ--DNA species may be attributed to the altered interaction of σ^54^ with −12 promoter sequence. Although some variants in DNA-binding domain also bound DNA poorly and less ssσ--DNA complexes were formed, the percentage of the initial bound DNA converted to ssσ--DNA is much higher compared to Cys(--)σ^54^, suggesting that for these Region I variants, poor DNA binding *per se* does not limit the isomerization of sigma--DNA complex. Indeed tight DNA binding at −12 may limit isomerization. It has been shown before that interaction of σ^54^ and −12 promoter sequence influences the regulation of open complex formation ([@B37],[@B39],[@B42]). Consistent with this, our results show a very clear correlation between Region I variants that have a defect in early melted DNA binding and their poor activities in activated transcription, contrasting the result that many other variants function normally in activated transcription, even if they have the same overall defect in early melted DNA binding ([Figure 1](#F1){ref-type="fig"}). It has been suggested that an α-helix in Region I could be required for normal σ^54^ function ([@B21]), and in our assay, it is interesting to note that mutations impairing DNA binding distribute periodically between residues 25--38 ([Figures 1](#F1){ref-type="fig"} and 5B).

Region I sequence binds core RNAP weakly and can be footprinted by core RNAP ([@B16],[@B31]), and our results identified the sequences in Region I contributing to this function, associated with inhibiting the RNA polymerase from making open complexes ([@B12]). It has been demonstrated previously that residue 36 is proximal to core RNAP ([@B25]). Consistent with this, our results show that mutations around residue 36 (residues 33--34 and 37--38) affect core RNAP binding slightly ([Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gkp419/DC1)). The variants with reduced core RNAP-binding activity are also impaired in σ^54^ isomerization and/or activator responsiveness, suggesting that the substituted residues contribute to the interface σ^54^ makes with core RNAP through which Region I exerts its influence upon holoenzyme to regulate function.

Roles of Region II sequences
----------------------------

Region II is very variable in sequence. Groups of acidic residues in Region II are involved in promoter melting and deletion of Region II affects holoenzyme formation and activator responsiveness of σ^54^ ([@B32],[@B43]). In our activator interaction assays, one Region II variant AC83/84, behaves differently from Cys(--)σ^54^ ([Figure 4](#F4){ref-type="fig"}), suggesting that an altered interaction with activator protein may occur. The activity of this variant in isomerized ss σ--DNA formation is also improved compared to Cys(--)σ^54^, implying the substituted residues may influence activator responsiveness ([Table 1](#T1){ref-type="table"}). However, we failed to identify any Region II variants significantly affecting the transcription activity of the assembled σ^54^-holoenzyme both *in vivo* and *in vitro*.

Roles of Region III sequences
-----------------------------

Region III includes a major determinant for core RNAP binding at its amino terminal and sequences for DNA binding located at the carboxyl terminal ([@B13],[@B15],[@B16]). In the cryo-EM reconstruction of σ^54^--holoenzyme, the primary core RNAP-binding domain and carboxyl terminal DNA-binding domain are assigned to D1 and D3, respectively, while some other Region III residues located in D2 with Region I contribute to maintaining the stable closed complex ([Figure 7](#F7){ref-type="fig"}) ([@B28],[@B41],[@B44],[@B45]).

Our data show that although the primary core RNAP-binding sequence is located between residues 120 and 215, many other residues outside this region also affect core RNAP binding ([Figure 3](#F3){ref-type="fig"}). This is consistent with the fact that sequences footprinted by core RNAP lie outside the primary core RNAP-binding domain, and are near or within the DNA-binding domain ([@B31]). On the basis of the model of the complex formed between the carboxyl terminal DNA-binding domain of σ^54^ (AAs 396--465) and promoter −24 sequence, it is proposed that the first loop of this domain may interact with the β-flap region of core RNAP ([@B20],[@B30]). Interestingly, we find that mutations between residues 423--426, which locate in the first loop of the carboxyl terminal DNA-binding domain based on the structure of σ^54^ from *A. aeolicus* ([Figure 1](#F1){ref-type="fig"}), indeed affect the core RNAP-binding activity ([Figure 3](#F3){ref-type="fig"}).

Residues affecting activator interaction are also distributed widely in Region III ([Figure 4](#F4){ref-type="fig"}). Since Region I is the major determinant for activator interaction ([@B33]), these Region III variants may influence activator interaction through the interaction between Regions III and I ([@B28],[@B41]). Region III variants affecting activator interaction can be divided into two classes. Class one variants are somewhat defective in activator interaction, but unlike Region I variants with this same phenotype, many of these Region III variants can still respond to activator protein. Class two variants can interact with activator protein, but an additional complex with slower mobility was formed ([Figure 4](#F4){ref-type="fig"}). This new complex has not been observed before and we suggest that this new complex might reflect a conformational change in the σ^54^-activator complex, implying an altered interaction of σ^54^ with activator protein. Residues around 307 have been proposed to be a site for activator interaction ([@B46]). Interestingly, our data show that mutations between residues 297 and 318 either lead to the failure of σ^54^ variants to form stable complex with activator protein, or the formation of an additional complex ([Table 1](#T1){ref-type="table"}), both cases reflecting the altered interaction with activator protein. Interactions that activator protein mediates between Regions III and I can be used to achieve the apparently concerted domain movements of σ^54^ seen in structural reconstructions of the PspF~1−275~ bound σ^54^-holoenzyme ([Figure 7](#F7){ref-type="fig"}) ([@B12]).

In contrast to the results of core RNAP-binding activity and σ^54^-activator interaction, residues affecting DNA binding are mainly located in the previously delineated DNA-binding domain, residues 329--477, fully consistent with the reconstruction model of σ^54^-holoenzyme--DNA complex where D2 and D3 densities cover −12 and −24 promoter sequences, with D1 containing the primary core RNAP-binding domain (residues 120--215). Based on the structure of the carboxyl terminal DNA-binding domain of σ^54^ from *A. aeolicus*, the residues D439, T457 and N471 of σ^54^ from *K. pneumoniae* can interact with −24 promoter sequence through hydrogen bonding ([@B30]). In accordance with this, our results show that substitutions of these three residues all affect the DNA-binding ability significantly ([Table 1](#T1){ref-type="table"}). Specific residues in modulation domain affecting DNA binding were also identified, confirming the view that modulation domain functions to assist DNA binding ([@B14]).

Unlike Region I variants, there is no close linkage between the defect in early melted DNA binding and ssσ--DNA formation. Among the DNA-binding defective variants in Region III, only three of them (AC295/296, 299/300 and 355/356) are defective for early melted DNA binding ([Table 1](#T1){ref-type="table"}). It has been suggested that residue 336 is proximal to −12 promoter sequence and interacts with sequences downstream to −12 GC element to regulate RNAP function together with Region I ([@B28],[@B41]). Thus, like the Region I variants, the defect of variant AC335/336 in ssσ--DNA formation could also result from the altered interaction of σ^54^ and the −12 promoter sequence. In contrast to the properties of these variants, in the carboxyl terminal DNA-binding domain variants defective in DNA binding (AC439/440, AC441/442, AC457/458 etc.) are not impaired in ssσ--DNA formation, indicating that it is an interaction with −12 promoter sequence that is crucial for σ^54^ isomerization, with the rpoN box providing the −24 promoter sequence contact that is not directly involved in the isomerization process. Variants AC295/296 and AC299/300 share the phenotype of AC335/336 and some Region I variants, implying that residues 295--300 located in the carboxyl terminal of modulation domain may also have a role in interactions with −12 promoter sequence, which may have a basis in communication with Region I.

Although most Region III variants are not impaired in ssσ--DNA formation, a distinctive class of variants is revealed on the basis of their greatly improved activities in ssσ--DNA formation. This class of variants can be roughly divided into two groups based on the linkage with other functional defects. Group I isomerization changed variants are represented by the variants in core RNAP-binding domain whose core RNAP-binding activities are impaired. Mutations leading to this phenotype are mainly located in two patches around residues 120 and 180 ([Figure 1](#F1){ref-type="fig"}). It has been suggested that some interactions between σ^54^ and core RNAP are changed upon isomerization of the σ^54^--DNA complex and recent structural analyses of the activator bound σ^54^-holoenzyme are in agreement with the activator causing a reorganization of σ^54^ domains within the holoenzyme ([@B12],[@B47]). The impaired core RNAP-binding activities of these variants described here may reflect an altered core RNAP-binding surface which is closer to the conformation of σ^54^ in the isomerized state, hence leading to the improved activity in isomerized ss σ--DNA formation. The activities of these σ^54^ variants in transcription assay are somehow impaired, suggesting that the substituted residues may contribute to the communication with core RNAP and that when they are substituted, σ^54^ isomerization is uncoupled from the changes that must occur in the core RNAP, required for the later stages of the DNA opening process and stable open complex formation ([@B48],[@B49]).

Group II isomerization changed variants are in the DNA-binding domain. For these variants there is a clear linkage between the defect in DNA binding and an improved activity in ssσ--DNA formation ([Figure 1](#F1){ref-type="fig"}). The weak contact these variants make with DNA may facilitate the changes in σ--DNA interactions which are important for ssσ--DNA complex formation ([@B33],[@B47]). However, increased formation of the ssσ--DNA complex has little overall effect on the normal function of holoenzyme in the context of *in vitro* transcription assays, arguing for the existence of other steps limiting open complex formation. For most of the variants in carboxyl terminal of σ^54^ (residues 431--476), the normal functions of the holoenzyme in *in vitro* transcription assay, together with their low expression levels *in vivo*, strongly indicates the carboxyl terminal of σ^54^ plays an important role in maintaining the structural integrity perhaps related to turnover of σ^54^ *in vivo*.

In conclusion, by constructing the single cysteine mutant library of σ^54^ and analyzing the functions of σ^54^ variants both *in vivo* and *in vitro*, σ^54^ sequences interacting with core RNAP, DNA and activator protein are systematically identified. Linkages between different functions are revealed and the possible mechanisms for those linkages are also discussed. Furthermore, the characterized σ^54^ library provides a powerful resource for functional analyses using site specific probes, and for interpretations of molecular structures.
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[^1]: +: σ^54^ variants bind PspF~1--275~ normally. +/−: σ^54^ variants bind PspF~1--275~ weakly. −: σ^54^ variants cannot bind PspF~1--275~.

[^2]: ^a^Activities in all the assays are measured relative to Cys(--)σ^54^. Isomerization ability of σ^54^ is calculated as a percentage of initially bound DNA converted to ssσ--DNA in an activator and dGTP dependent way.

[^3]: ^b^Tested using β-galactosidase assay.

[^4]: ^c^New complexes were formed when PspF~1--275~ was trapped with σ^54^ in the presence of ADP·AlFx.

[^5]: ^d^Low level of *in vivo* expression.
